News | February 10, 2024
Biocon Biologics partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab
The agreement is effective from January 1, 2024 and commercialisation commenced on February 1, 2024
The agreement is effective from January 1, 2024 and commercialisation commenced on February 1, 2024
Ayush is expanding beyond wellness to therapeutic wellness
The company will be managing orders and warehouse operations for Little's, Lacto-calamine, Tri-activ, I-feel, Ourdaily, and Sloan's through the Unicommerce platform
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
The Institute is catering the health needs of the surrounding population with ever-increasing OPD every year along with special OPDs like mother & Child OPD, and LSD clinic
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
He is also inducted as a member of the management council and senior management personnel of the company
Subscribe To Our Newsletter & Stay Updated
